Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532317) titled 'A Prospective, Multinational, Multicentre, Open-label, Randomized Trial to Evaluatesafety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared toGuideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis' on April 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Meril Life Sciences Pvt. Ltd.
Condition:
Moderate Aortic Valve Stenosis
Intervention:
Device: Transcatheter aortic valve replacement
Recruitment Status: Not recr...